105 related articles for article (PubMed ID: 20233624)
1. The interaction of coagulation factor XII and monocyte/macrophages mediating peritoneal metastasis of epithelial ovarian cancer.
Wang R; Zhang T; Ma Z; Wang Y; Cheng Z; Xu H; Li W; Wang X
Gynecol Oncol; 2010 Jun; 117(3):460-6. PubMed ID: 20233624
[TBL] [Abstract][Full Text] [Related]
2. Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients.
Gordon IO; Freedman RS
Clin Cancer Res; 2006 Mar; 12(5):1515-24. PubMed ID: 16533776
[TBL] [Abstract][Full Text] [Related]
3. Interaction of coagulation factors and tumor-associated macrophages mediates migration and invasion of gastric cancer.
Ma YY; He XJ; Wang HJ; Xia YJ; Wang SL; Ye ZY; Tao HQ
Cancer Sci; 2011 Feb; 102(2):336-42. PubMed ID: 21134074
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor-factor VIIa complex induces epithelial ovarian cancer cell invasion and metastasis through a monocytes-dependent mechanism.
Ma Z; Zhang T; Wang R; Cheng Z; Xu H; Li W; Wang Y; Wang X
Int J Gynecol Cancer; 2011 May; 21(4):616-24. PubMed ID: 21543928
[TBL] [Abstract][Full Text] [Related]
5. Thrombin facilitates invasion of ovarian cancer along peritoneum by inducing monocyte differentiation toward tumor-associated macrophage-like cells.
Zhang T; Ma Z; Wang R; Wang Y; Wang S; Cheng Z; Xu H; Jin X; Li W; Wang X
Cancer Immunol Immunother; 2010 Jul; 59(7):1097-108. PubMed ID: 20352429
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of immune inhibitory cytokine profiles in epithelial ovarian carcinoma.
Chen LL; Ye F; Lü WG; Yu Y; Chen HZ; Xie X
J Obstet Gynaecol Res; 2009 Apr; 35(2):212-8. PubMed ID: 19335794
[TBL] [Abstract][Full Text] [Related]
7. Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice.
Robinson-Smith TM; Isaacsohn I; Mercer CA; Zhou M; Van Rooijen N; Husseinzadeh N; McFarland-Mancini MM; Drew AF
Cancer Res; 2007 Jun; 67(12):5708-16. PubMed ID: 17575137
[TBL] [Abstract][Full Text] [Related]
8. M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.
Leidi M; Gotti E; Bologna L; Miranda E; Rimoldi M; Sica A; Roncalli M; Palumbo GA; Introna M; Golay J
J Immunol; 2009 Apr; 182(7):4415-22. PubMed ID: 19299742
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of peritoneum and tumor eicosanoids and pathways in advanced ovarian cancer.
Freedman RS; Wang E; Voiculescu S; Patenia R; Bassett RL; Deavers M; Marincola FM; Yang P; Newman RA
Clin Cancer Res; 2007 Oct; 13(19):5736-44. PubMed ID: 17908963
[TBL] [Abstract][Full Text] [Related]
10. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
12. Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
Karam AK; Stempel M; Barakat RR; Morrow M; Gemignani ML
Gynecol Oncol; 2009 Mar; 112(3):490-5. PubMed ID: 19101713
[TBL] [Abstract][Full Text] [Related]
13. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase.
Chambers SK; Wang Y; Gertz RE; Kacinski BM
Cancer Res; 1995 Apr; 55(7):1578-85. PubMed ID: 7882368
[TBL] [Abstract][Full Text] [Related]
14. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
Zhang J; Wang B
Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393
[TBL] [Abstract][Full Text] [Related]
16. Gender dimorphism of macrophage response to GMCSF and IL-4 for differentiation into dendritic cells.
Gupta V; Singh SM
Am J Reprod Immunol; 2008 Jul; 60(1):43-54. PubMed ID: 18593437
[TBL] [Abstract][Full Text] [Related]
17. S1P regulation of ovarian carcinoma invasiveness.
Smicun Y; Reierstad S; Wang FQ; Lee C; Fishman DA
Gynecol Oncol; 2006 Dec; 103(3):952-9. PubMed ID: 16956652
[TBL] [Abstract][Full Text] [Related]
18. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
20. Role of CXCL12 in metastasis of human ovarian cancer.
Jiang YP; Wu XH; Xing HY; DU XY
Chin Med J (Engl); 2007 Jul; 120(14):1251-5. PubMed ID: 17697577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]